Navigation Links
Radiation before surgery cuts cancer reappearance

According to a report, giving radiation to surgical treatment for rectal cancer may not make much difference in the survival of patients. But the findings suggest that the radiation treatments given before surgery may help// improve the patient's quality of life by reducing the rate of cancer recurrence at or near the original tumor site in the rectum.

In about 15% to 45% of patients who undergo conventional surgery to remove rectal tumors, they return. To prevent recurrence, surgeons have developed a technique called total mesorectal excision, in which the tissue surrounding the rectum, which may contain tumor cell, is removed along with the rectum itself.

In order to investigate researchers randomly assigned more than 1,800 patients to have either total mesorectal excision alone, or the surgery along with radiation given beforehand.

According to Dr. Ellen Kapit and colleagues from Leiden University Medical Center in New Jersy, among patients who received both radiation treatment and surgery, 2.4% saw a reappearance of their cancer. Patients in the surgery-only group had a recurrence rate of 8.2%. They concluded that radiation before surgery can improve local control of the disease.

Drs. Heidi Nelson and Daniel J. Sargent of the Mayo Clinic in Rochester, Minnesota, wrote in an accompanying editorial that the preliminary results show that radiation therapy does provide an additional benefit: radiation therapy reduced the risk of local recurrence even when administered to patients who underwent total mesorectal excision.


'"/>




Page: 1

Related medicine news :

1. Radiation before surgery cuts cancer recurrence
2. UV Radiation induces Melanoma
3. Radiation reduces cancer recurrence
4. Radiation Not Needed for Childhood Cancers
5. Does Radiation Cause Lung Cancer?
6. Radiation for Bone Pain
7. Radiation for Bone Pain
8. Radiation after Breast Reconstruction
9. Radiation Exposure Found To Affect Intellect Later In Life
10. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
11. Radiation Therapy for Prostate Cancer Tolerated Well by Elderly Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Building on the ... Louisiana became the sixth state to pass legislation which ensures that children can ... signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah and Washington who ...
(Date:6/27/2017)... ... 2017 , ... The Kelahan Agency, a privately owned firm ... southern New Hampshire, is teaming up with the New Horizons for New Hampshire ... the region. , New Horizons for New Hampshire provides a wealth of services ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: